dihexa hgf c-met cancer risk HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Dihexa targets neurotrophic factors like
Dihexa targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c MET receptor, it helps cells take in nutrients and rebuildespecially in cases where recovery is Role of the HGF c MET tyrosine kinase inhibitors in metastasic melanoma Molecular Cancer Springer Nature Link The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth HGF and MET: From Brain Development to Neurological Disorders PMC
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12




